U.S. stocks were mixed, with the Dow Jones index gaining around 100 points on Monday.
Shares of First Tracks Biotherapeutics, Inc. (NASDAQ:TRAX) rose sharply after the company released topline results from Cohort 1 of its Phase 1b clinical trial of ANB033 in celiac disease.
The clinical-stage biotechnology firm designed ANB033 as an investigational, subcutaneously administered CD122 antagonist to block IL-15 and IL-2 signaling on immune cells. During a 14-day gluten challenge, the candidate protected against gluten-induced intestinal damage and prevented symptom aggravation in study subjects.
First Tracks Biotherapeutics shares jumped 18% to $37.36 on Monday.
Here are some other big stocks recording gains in today’s session.
- C3.ai, Inc. (NYSE:AI) rose 10.7% to $12.75 after Northland upgraded the stock to Outperform from Market Perform and raised its price target to $16 from $10.
- Liquidia Corporation (NASDAQ:LQDA) gained 8.4% to $29.70.
- Borr Drilling Limited (NYSE:BORR) climbed 8.3% to $5.17.
- Allot Ltd. (NASDAQ:ALLT) rose 8.1% to $9.07.
- CCC Intelligent Solutions Holdings Inc. (NASDAQ:CCC) gained 7.6% to $7.55 after reports suggesting that GTCR and Elliott Investment Management are close to a deal to acquire the company.
- American Bitcoin Corp (NASDAQ:ABTC) rose 7% to $8.27. HC Wainwright & Co. analyst Mike Colonnese assumed American Bitcoin with a Buy rating and announced a price target of $22.
- Cypherpunk Technologies Inc. (NASDAQ:CYPH) gained 6.3% to $3.14.
- Manhattan Associates, Inc. (NASDAQ:MANH) rose 6.2% to $217.49.
- Okeanis Eco Tankers Corp. (NYSE:ECO) gained 6% to $98.68.
- AST SpaceMobile, Inc. (NASDAQ:ASTS) rose 6% to $54.05 after Deutsche Bank upgraded its rating on the stock from Hold to Buy and maintained its $93 price target.
Photo via Shutterstock